Health-related quality of life in patients with COVID-19; international development of a patient-reported outcome measure.
COVID-19
PROM
Patient-reported outcome measure
Quality of life
Questionnaire
Symptoms
Journal
Journal of patient-reported outcomes
ISSN: 2509-8020
Titre abrégé: J Patient Rep Outcomes
Pays: Germany
ID NLM: 101722688
Informations de publication
Date de publication:
26 Mar 2022
26 Mar 2022
Historique:
received:
01
10
2021
accepted:
08
03
2022
entrez:
29
3
2022
pubmed:
30
3
2022
medline:
30
3
2022
Statut:
epublish
Résumé
We aimed to create a questionnaire to assess the health-related quality of life including functioning, symptoms, and general health status of adult patients with current or previous COVID-19. Here, we report on Phase I and II of the development. Internationally recognized methodology for questionnaire development was followed. In Phase I, a comprehensive literature review was performed to identify relevant COVID-19 issues. Decisions for inclusion, exclusion, and data extraction were completed independently in teams of two and then compared. The resulting issues were discussed with health care professionals (HCPs) and current and former COVID-19 patients. The input of HCPs and patients was carefully considered, and the list of issues updated. In Phase II, this updated list was operationalized into items/questions. The literature review yielded 3342 publications, 339 of which were selected for full-text review, and 75 issues were identified. Discussions with 44 HCPs from seven countries and 52 patients from six countries showed that psychological symptoms, worries, and reduced functioning lasted the longest for patients, and there were considerable discrepancies between HCPs and patients concerning the importance of some of the symptoms. The final list included 73 issues, which were operationalized into an 80-item questionnaire. The resulting COVID-19 questionnaire covers health-related quality of life issues relevant to COVID-19 patients and is available in several languages. The next steps include testing of the applicability and patients' acceptability of the questionnaire (Phase IIIA) and preliminary psychometric testing (Phase IIIB).
Sections du résumé
BACKGROUND
BACKGROUND
We aimed to create a questionnaire to assess the health-related quality of life including functioning, symptoms, and general health status of adult patients with current or previous COVID-19. Here, we report on Phase I and II of the development.
METHODS
METHODS
Internationally recognized methodology for questionnaire development was followed. In Phase I, a comprehensive literature review was performed to identify relevant COVID-19 issues. Decisions for inclusion, exclusion, and data extraction were completed independently in teams of two and then compared. The resulting issues were discussed with health care professionals (HCPs) and current and former COVID-19 patients. The input of HCPs and patients was carefully considered, and the list of issues updated. In Phase II, this updated list was operationalized into items/questions.
RESULTS
RESULTS
The literature review yielded 3342 publications, 339 of which were selected for full-text review, and 75 issues were identified. Discussions with 44 HCPs from seven countries and 52 patients from six countries showed that psychological symptoms, worries, and reduced functioning lasted the longest for patients, and there were considerable discrepancies between HCPs and patients concerning the importance of some of the symptoms. The final list included 73 issues, which were operationalized into an 80-item questionnaire.
CONCLUSION
CONCLUSIONS
The resulting COVID-19 questionnaire covers health-related quality of life issues relevant to COVID-19 patients and is available in several languages. The next steps include testing of the applicability and patients' acceptability of the questionnaire (Phase IIIA) and preliminary psychometric testing (Phase IIIB).
Identifiants
pubmed: 35348945
doi: 10.1186/s41687-022-00434-1
pii: 10.1186/s41687-022-00434-1
pmc: PMC8962286
doi:
Types de publication
Journal Article
Langues
eng
Pagination
26Informations de copyright
© 2022. The Author(s).
Références
Huang C, Wang Y, Li X et al (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395(10223):497–506
doi: 10.1016/S0140-6736(20)30183-5
Halpin SJ, McIvor C, Whyatt G et al (2020) Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: a cross-sectional evaluation. J Med Virol 93:1013–1022
doi: 10.1002/jmv.26368
Daher A, Balfanz P, Cornelissen C et al (2020) Follow up of patients with severe coronavirus disease 2019 (COVID-19): pulmonary and extrapulmonary disease sequelae. Respir Med 174:106197
doi: 10.1016/j.rmed.2020.106197
Xiong Q, Xu M, Li J et al (2021) Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study. Clin Microbiol Infect 27(1):89–95
doi: 10.1016/j.cmi.2020.09.023
Bjordal K, Kaasa S (1992) Psychometric validation of the EORTC Core Quality of Life Questionnaire, 30-item version and a diagnosis-specific module for head and neck cancer patients. Acta Oncol 31(3):311–321. https://doi.org/10.3109/02841869209108178
doi: 10.3109/02841869209108178
pubmed: 1622651
Gopichandran V (2020) Clinical ethics during the Covid-19 pandemic: Missing the trees for the forest. Indian J Med Ethics 05:182–187
doi: 10.20529/IJME.2020.053
Ozma MA, Maroufi P, Khodadadi E et al (2020) Clinical manifestation, diagnosis, prevention and control of SARS-CoV-2 (COVID-19) during the outbreak period. Infez Med 28(2):153–165
pubmed: 32275257
Lake MA (2020) What we know so far: COVID-19 current clinical knowledge and research. Clin Med (Lond) 20(2):124–127
doi: 10.7861/clinmed.2019-coron
Mahe A, Birckel E, Krieger S et al (2020) A distinctive skin rash associated with Coronavirus disease 2019 ? J Eur Acad Dermatol Venereol. https://doi.org/10.1111/jdv.16471
doi: 10.1111/jdv.16471
pubmed: 33289175
pmcid: 7984225
Lechien JR, Chiesa-Estomba CM, De Siati DR et al (2020) Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol [Internet] 277:2251–2261
doi: 10.1007/s00405-020-05965-1
Mao L, Jin H, Wang M et al (2020) Neurologic manifestations of hospitalized patients with Coronavirus disease 2019 in Wuhan, China. JAMA Neurol 77:683–690
doi: 10.1001/jamaneurol.2020.1127
Graham J (2020) Seniors with Covid-19 show unusual symptoms, doctors say: CNN; 2020 [updated 23.04.2020]. https://edition.cnn.com/2020/04/23/health/seniors-elderly-coronavirus-symptoms-wellness-partner/index.html
Hamm BS, Rosenthal LJ (2020) Psychiatric aspects of chloroquine and hydroxychloroquine treatment in the wake of coronavirus disease-2019: psychopharmacological interactions and neuropsychiatric sequelae. Psychosomatics 61(6):597–606
doi: 10.1016/j.psym.2020.06.022
Kim MS, An MH, Kim WJ et al (2020) Comparative efficacy and safety of pharmacological interventions for the treatment of COVID-19: a systematic review and network meta-analysis. PLoS Med 17(12):e1003501
doi: 10.1371/journal.pmed.1003501
Liu K, Zhang W, Yang Y et al (2020) Respiratory rehabilitation in elderly patients with COVID-19: a randomized controlled study. Complement Ther Clin Pract 39:101166
doi: 10.1016/j.ctcp.2020.101166
Team Th (2021) Health Measures Transforming how health is measured [cited 2021 05.03.2021]. https://www.healthmeasures.net/explore-measurement-systems/promis
Chopra S, Ranjan P, Malhotra A et al (2020) Development and validation of a questionnaire to evaluate the impact of COVID-19 on lifestyle-related behaviours: eating habits, activity and sleep behaviour. Public Health Nutr 24:1275–1290
doi: 10.1017/S1368980020004656
Di Renzo L, Gualtieri P, Pivari F et al (2020) Eating habits and lifestyle changes during COVID-19 lockdown: an Italian survey. J Transl Med 18(1):229
doi: 10.1186/s12967-020-02399-5
Johnson C, Aaronson N, Blazeby JM, et al (2011) Guidelines for Developing Questionnaire Modules. 4th ed. Brussels: EORTC.
Moher D, Liberati A, Tetzlaff J et al (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 339:b2535
doi: 10.1136/bmj.b2535
PROSPERO 2020 CRD42020185995 2020. https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42020185995
Amdal CD, Pe M, Falk RS, Piccinin C, Bottomley A, Arraras JI et al (2021) Health-related quality of life issues, including symptoms, in patients with active COVID-19 or post COVID-19; a systematic literature review. Qual Life Res. https://doi.org/10.1007/s11136-021-02908-z
doi: 10.1007/s11136-021-02908-z
pubmed: 34350566
pmcid: 8921167
EORTC QLG Item Library 2018. https://qol.eortc.org/item-library/
Kuliś D, Bottomley A, Whittaker C, et al (2017) The use of the EORTC item library to supplement EORTC quality of life instruments. In; The international society for pharmacoeconomics and outcomes research (ISPOR) 20th annual European congress; 2017 Nov 4–8; Glasgow, Scotland, 2017
Kuliś D, Whittaker C, Greimel E, Bottomley A, Koller M, EORTC Quality of Life Group (2017) Reviewing back translation reports of questionnaires: the EORTC conceptual framework and experience. Expert Rev Pharmacoecon Outcomes Res 17(6):523–530. https://doi.org/10.1080/14737167.2017.1384316
doi: 10.1080/14737167.2017.1384316
pubmed: 28974101
Gamper E-M, Petersen MA, Aaronson N et al (2016) Development of an item bank for the EORTC role functioning computer adaptive test (EORTC RF-CAT). Health Qual Life Outcomes 14(1):72
doi: 10.1186/s12955-016-0475-x
Kissler SM, Tedijanto C, Goldstein E et al (2020) Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period. Science 368(6493):860–868
doi: 10.1126/science.abb5793
Li Y, Wang X, Nair H (2020) Global seasonality of human seasonal coronaviruses: a clue for postpandemic circulating season of severe acute respiratory syndrome coronavirus 2? J Infect Dis 222(7):1090–1097
doi: 10.1093/infdis/jiaa436
RAND_HEALTH_CARE. Surveys_tools 2020. https://www.rand.org/health-care/surveys_tools/mos/36-item-short-form.html
The EuroQol Group (1990) EuroQol-a new facility for the measurement of health-related quality of life. Health Policy 16(3):199–208
doi: 10.1016/0168-8510(90)90421-9
Struyf T, Deeks JJ, Dinnes J et al (2021) Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19. Cochrane Database Syst Rev 2:Cd013665
pubmed: 33620086
Townsend L, Dyer AH, Jones K et al (2020) Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection. PLoS ONE [Electron Resour] 15(11):e0240784
doi: 10.1371/journal.pone.0240784
Mizrahi B, Shilo S, Rossman H et al (2020) Longitudinal symptom dynamics of COVID-19 infection. Nat Commun 11(1):6208
doi: 10.1038/s41467-020-20053-y
Rolstad S, Adler J, Rydén A (2011) Response burden and questionnaire length: is shorter better? A review and meta-analysis. Value Health 14(8):1101–1108
doi: 10.1016/j.jval.2011.06.003
Koller M, Shamieh O, Hjermstad MJ et al (2020) Psychometric properties of the updated EORTC module for assessing quality of life in patients with lung cancer (QLQ-LC29): an international, observational field study. Lancet Oncol 21(5):723–732
doi: 10.1016/S1470-2045(20)30093-0
Singer S, Amdal CD, Hammerlid E et al (2019) International validation of the revised European Organisation for Research and Treatment of Cancer Head and Neck Cancer Module, the EORTC QLQ-HN43: Phase IV. Head Neck 41(6):1725–1737
doi: 10.1002/hed.25609
Patrick DL, Burke LB, Powers JH et al (2007) Patient-reported outcomes to support medical product labeling claims: FDA perspective. Value Health 10(Suppl 2):S125–S137
doi: 10.1111/j.1524-4733.2007.00275.x